Lieveke Ameye

10.6k total citations
215 papers, 7.0k citations indexed

About

Lieveke Ameye is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Lieveke Ameye has authored 215 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 56 papers in Obstetrics and Gynecology and 39 papers in Reproductive Medicine. Recurrent topics in Lieveke Ameye's work include Breast Cancer Treatment Studies (25 papers), Ovarian cancer diagnosis and treatment (24 papers) and Endometrial and Cervical Cancer Treatments (24 papers). Lieveke Ameye is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Ovarian cancer diagnosis and treatment (24 papers) and Endometrial and Cervical Cancer Treatments (24 papers). Lieveke Ameye collaborates with scholars based in Belgium, Italy and United Kingdom. Lieveke Ameye's co-authors include D. Timmerman, Marian F. Young, Marianne Paesmans, Sabine Van Huffel, T. Bourne, L. Valentin, A. C. Testa, Ignace Vergote, C. Van Holsbeke and Martine Piccart and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Lieveke Ameye

202 papers receiving 6.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lieveke Ameye Belgium	43	2.0k	1.9k	1.8k	1.1k	798	215	7.0k
Kathryn Osann United States	54	2.4k 1.2×	1.5k 0.8×	2.3k 1.2×	1.5k 1.4×	455 0.6×	196	8.4k
Sara Y. Brucker Germany	37	1.1k 0.5×	1.0k 0.6×	2.3k 1.3×	756 0.7×	892 1.1×	293	5.6k
Wiebren Tjalma Belgium	40	977 0.5×	1.6k 0.8×	926 0.5×	1.5k 1.4×	275 0.3×	258	5.3k
Klaus Friese Germany	45	971 0.5×	2.4k 1.3×	1.5k 0.8×	840 0.7×	771 1.0×	275	7.9k
Bobbie S. Gostout United States	40	2.8k 1.4×	887 0.5×	2.9k 1.6×	1.2k 1.1×	507 0.6×	92	6.6k
Andrew Bryant United Kingdom	40	1.8k 0.9×	1.1k 0.6×	1.9k 1.1×	1.4k 1.3×	392 0.5×	110	5.2k
Christof Sohn Germany	46	494 0.2×	2.3k 1.2×	1.0k 0.6×	975 0.9×	1.1k 1.4×	303	7.7k
D. Wallwiener Germany	54	1.4k 0.7×	5.0k 2.7×	2.0k 1.1×	1.9k 1.7×	1.1k 1.4×	608	12.8k
Loren K. Mell United States	50	521 0.3×	2.5k 1.3×	2.1k 1.1×	2.9k 2.6×	328 0.4×	243	8.9k
A. C. Testa Italy	47	5.7k 2.8×	594 0.3×	4.7k 2.6×	2.3k 2.1×	452 0.6×	279	7.9k

Countries citing papers authored by Lieveke Ameye

Since Specialization

Citations

This map shows the geographic impact of Lieveke Ameye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieveke Ameye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieveke Ameye more than expected).

Fields of papers citing papers by Lieveke Ameye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieveke Ameye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieveke Ameye. The network helps show where Lieveke Ameye may publish in the future.

Co-authorship network of co-authors of Lieveke Ameye

This figure shows the co-authorship network connecting the top 25 collaborators of Lieveke Ameye. A scholar is included among the top collaborators of Lieveke Ameye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieveke Ameye. Lieveke Ameye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martins-Branco, Diogo, Philippe Aftimos, Brooke Pereira, et al.. (2024). 355P EVERolimus effectiveness after proGREssion on CDK4/6 inhibitors for ENdocrine receptor-positive/HER2-negative, advanced breast cancer: EVERGREEN quasi-experimental study. Annals of Oncology. 35. S365–S366. 1 indexed citations

Ameye, Lieveke, et al.. (2024). Management and outcome of oncological patients under immune checkpoint inhibitors presenting at the emergency department. Emergency Medicine Journal. 41(7). 417–421. 1 indexed citations

Maslin, Kate, Lieveke Ameye, Anne Rochtus, et al.. (2024). Interpregnancy maternal weight change is not associated with offspring weight and obesity at age 2 years. International Journal of Obesity. 48(10). 1402–1413. 3 indexed citations

Artigas, Carlos, Hugo Levillain, Lieveke Ameye, et al.. (2024). 177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors. Clinical Nuclear Medicine. 49(9). 847–853. 5 indexed citations

Martins-Branco, Diogo, Guilherme Nader Marta, Chiara Molinelli, et al.. (2023). Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis. European Journal of Cancer. 194. 113358–113358. 7 indexed citations

Martins-Branco, Diogo, Guilherme Nader Marta, Véronique Debien, et al.. (2022). Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 149(7). 3075–3080. 9 indexed citations

Gombos, Andrea, David Venet, Lieveke Ameye, et al.. (2021). FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. npj Breast Cancer. 7(1). 125–125. 14 indexed citations

Maslin, Kate, et al.. (2021). Phase Angle and Bio-Impedance Values during the First Year after Delivery in Women with Previous Excessive Gestational Weight Gain: Innovative Data from the Belgian INTER-ACT Study. International Journal of Environmental Research and Public Health. 18(14). 7482–7482. 2 indexed citations

Levillain, Hugo, Lieveke Ameye, Thomas Guiot, et al.. (2019). Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study. European Journal of Nuclear Medicine and Molecular Imaging. 46(11). 2270–2279. 48 indexed citations

10.

Ameye, Lieveke, M Paesmans, Alexandre de Wind, et al.. (2018). Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation. PubMed. 39(5). 420–427. 2 indexed citations

11.

Al‐Memar, M., Srdjan Saso, S. Bobdiwala, et al.. (2017). Validation of a virtual reality simulator for the use of transvaginal ultrasonography in gynaecology and early pregnancy. Australasian Journal of Ultrasound in Medicine. 20(3). 97–105. 6 indexed citations

12.

Božović‐Spasojević, Ivana, Dimitrios Zardavas, Sylvain Brohée, et al.. (2016). The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data. Clinical Cancer Research. 23(11). 2702–2712. 84 indexed citations

13.

Aftimos, Philippe, Lieveke Ameye, Christiane Jungels, et al.. (2016). Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial. European Journal of Cancer. 60(29). 117–124. 20 indexed citations

14.

Azambuja, Evandro de, Lieveke Ameye, Marianne Paesmans, et al.. (2013). The landscape of medical oncology in Europe by 2020. European Journal of Cancer. 49. 1 indexed citations

15.

Ameye, Lieveke, L. Valentin, A. C. Testa, et al.. (2008). A scoring system to differentiate malignant from benign masses in specific ultrasound‐based subgroups of adnexal tumors. Ultrasound in Obstetrics and Gynecology. 33(1). 92–101. 25 indexed citations

16.

Durbecq, Virginie, Lieveke Ameye, Isabelle Veys, et al.. (2008). A significant proportion of elderly patients develop hormone-dependant “luminal-B” tumours associated with aggressive characteristics. Critical Reviews in Oncology/Hematology. 67(1). 80–92. 44 indexed citations

17.

Ameye, Lieveke, Michel Moreau, & Marianne Paesmans. (2007). Incidence and Mortality in Breast Cancer: Are We Doing Better?. 2(3). 111–117. 1 indexed citations

18.

Henrotin, Yves, et al.. (2004). Dietary supplementation with chondroitin sulfate and glucosamine HCL does not slow down articular cartilage erosion in biglycan/fibromodulin deficient mice. Open Repository and Bibliography (University of Liège). 1 indexed citations

19.

Goldberg, Michel, D. Septier, Karima Palmier, et al.. (2003). Proteoglycans in Predentin: The Last 15 Micrometers Before Mineralization. Connective Tissue Research. 44(1). 184–188. 41 indexed citations

20.

Morales, Leilani, Patrick Neven, D. Timmerman, et al.. (2003). Prospective study on the effect of endocrine treatments on menopausal symptoms in breast cancer patients. Breast Cancer Research and Treatment. 82. 106–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact